Rationale: Myocardial infarction (MI) leads to heart failure (HF) and premature death. The respective roles of myocyte death and depressed myocyte contractility in the induction of HF after MI have not been clearly defined and are the focus of this study.
V ascular disease can lead to interruption of blood flow to the heart (myocardial infarction [MI] ). The resulting loss of contractile mass causes an acute reduction in cardiac pump function. Cardiac output and blood pressure are initially maintained by activation of sympathetic reflex responses that increase myocyte contractility in regions of the heart where blood flow is maintained. Soon after MI, the ventricles begin to remodel (dilate), which further increases the work demands (systolic wall stress) on the surviving myocardium.
Myocyte contractility is increased after MI through activation of adrenergic signaling pathways that increase Ca 2ϩ influx and sarcoplasmic reticulum (SR) uptake, storage, and release. The increased myocyte Ca 2ϩ transients that enhance contractile function after MI are also thought to induce myocyte hypertrophy, [1] [2] [3] increasing contractile mass and partially normalizing the increased systolic wall stress. However, persistent pathological stress in the remodeled, post-MI heart is associated with abnormal myocyte contractile properties 4, 5 and increases in the rate of myocyte death. 6 -8 These two changes develop with congestive heart failure (CHF) and increase during its progression. 6, 9 The respective contributions of myocyte contractile abnormalities (weak myocytes) and myocyte death (not enough myocytes) in the induction and progression of HF after MI is still not clearly defined. We studied this issue by preventing depression of myocyte contractile function in genetically modified mice subjected to MI.
Persistent pathological stress (MI and hypertension) induces abnormalities in myocyte Ca 2ϩ handling 5, 10 and sympathetic signaling cascades. 11 SR Ca 2ϩ uptake rates are slowed; Ca 2ϩ transient and action potential durations are prolonged 5, 12 ; and inotropic responses to sympathetic agonists are blunted. 13 These changes are centrally involved in the slowing of contraction and relaxation rates, prolongation of contractile duration, and depressed contractility reserve. 14, 15 What is still not clear is whether these Ca 2ϩ handling alterations induce cardiac decompensation and cause its progression or whether they are secondary to the ever increasing demand for enhanced myocyte function in the pathological heart.
The depressed myocyte contractility hypothesis predicts that HF therapies that increase myocyte contractility will improve cardiac pump function, HF symptoms, and survival. Unfortunately, most inotropic therapies that have been tested in patients over the past few decades have either had no effect on survival 16 or have increased death rates. 17, 18 Therapies 19 that have clinical benefit in HF, inhibitors of excess reninangiotensin and ␤-adrenergic signaling, reduce rather than enhance myocyte contractility, 19, 20 suggesting that myocyte contractile abnormalities in HF might be the consequence of the excessive contractility demands rather than the cause of HF per se.
HF induction and progression is also associated with an increased rate of myocyte death from apoptosis and necrosis. 8 Excessive activation of sympathetic and renin-angiotensin signaling pathways in HF, 21 as well as oxidative stress, cytokine accumulation, 22 and persistent activation of Ca 2ϩ signaling, 3, 23, 24 are all thought to contribute. 25, 26 Our working hypothesis is that excessive demands for contractility in HF increase cell death and it is cell death rather than reduced myocyte contractile function that causes HF progression.
The objective of our present study was to determine whether preventing depressed myocyte contractility after MI, without activating the sympathetic nervous system, improves cardiac pump function and slows CHF progression. To explore this topic we developed a genetically modified mouse in which we could increase Ca 2ϩ influx by conditional, cardiac specific overexpression of the ␤2a subunit of the L-type Ca 2ϩ channel (termed ␤2a mice). 8 This approach increases Ca 2ϩ influx and myocyte contractility 26, 27 without requiring sympathetic nerve activity. If depressed myocyte contractility causes abnormal pump function and CHF after MI, then we would expect better cardiac pump function in our ␤2a mice in which depressed myocyte contractility is prevented. If on the other hand the remodeling of myocyte Ca 2ϩ handling after MI is a response to the excessive demands for enhanced function, and in part this remodeling protects the myocyte from Ca 2ϩ -mediated damage, then maintaining high Ca 2ϩ might increase myocyte death and exacerbate the depression of cardiac pump function.
Methods
All methods have been described in detail in previous reports and are described in detail in the Online Data Supplement, available http:// circres.ahajournals.org. Briefly, myocardial infarction was induced in wild-type and ␤2a transgenic mice by permanent occlusion of the left anterior descending coronary artery. Cardiac function was measured with echocardiography. At euthanasia, hearts were removed and used for functional studies (isovolumic hearts and isolated single ventricular myocytes [VMs]), tissue was used for Western or biochemical analyses, or hearts were fixed and processed for histological studies.
Results

␤2a-LTCC Hearts Are Hypercontractile
Mice with conditional, cardiac-specific, low-level expression of Cav1.2 ␤2a were used ( Figure 1A ). 8 A modified ␣-myosin heavy chain promoter was used for cardiac-specific expression of the ␤2a gene, and mice containing both tTA (tetracycline-controlled transactivator) and ␤2a transgenes (double transgenic) allowed for doxycycline (Dox) suppression of ␤2a expression (Dox-off system) during development. Mice were taken off Dox-containing chow after weaning (at 21 days) and used at 4 to 6 months of age, because at this age, the ␤2a gene was fully expressed and mice showed enhanced cardiac performance ( Figure 1B) , with no signs of cardiomyopathy. 8 ␤2a mice had increased ejection fraction (EF) ( Figure 1C ) and fractional shortening (FS) ( Figure 1D ) versus controls. Posterior wall thickness (PWT) and septal wall thickness were greater and left ventricular (LV) internal diameter was smaller (LVID) in ␤2a animals ( Figure 1E , 1F, and 1G). These data show that ␤2a hearts were hypercontractile with modest LV hypertrophy ( Figure 1H ).
Infarct Size Is Increased in ␤2a Hearts Because of Increased Myocyte Death
MI was induced by interruption of blood flow to the LV via left anterior descending coronary artery (LAD). The area of the heart with interrupted blood flow was identical in control and ␤2a hearts (area at risk [AAR]; control versus ␤2a: 45.1Ϯ3.2% versus 50.4Ϯ6.8%; Figure 2A ; Online Figure I , A). However, myocardial infarct size (as a % of AAR) was significantly larger in ␤2a mice than in controls (control versus ␤2a: 45.3Ϯ6.1% versus 83.8Ϯ14.4%) ( Figure 2B ; Online Figure I Figure 2G ). Myocyte death is associated with replacement fibrosis 28 and the collagen content of ␤2a hearts was significantly greater than in controls and increased to a greater extent with time after MI ( Figure 2H ). Ki67 (proliferative marker) labeling was greater in ␤2a versus WT hearts MI and ischemia/reperfusion (I/R) causes more cell death in ␤2a hearts. A, AAR was not different in control (nϭ15) and ␤2a hearts (nϭ6). B, Infarct size (% of AAR) in hearts with 30 minutes of ischemia followed by 24 hours of reperfusion (I/R) was greater in ␤2a (nϭ6) than in control hearts (nϭ8). C, Infarct length after permanent occlusion was greater in ␤2a (nϭ6) than in controls (nϭ7) and. D through F, Myocytes per 10 6 undergoing apoptosis in the border and remote zones of control (nϭ3) and ␤2a hearts (nϭ4). G, Caspase 3 activity in remote zone tissues (control, nϭ9; ␤2a, nϭ10). H, Fibrotic area (blue) in remote zones of trichrome-stained cardiac histological sections from control (nϭ3) and ␤2a hearts (nϭ3). I, Ki67
ϩ myocytes per 10 6 in control (nϭ3) and ␤2a hearts (nϭ4) after MI. *PϽ0.05; **PϽ0.01. Collectively these results show that there is an increased rate of death of ␤2a myocytes after MI stress, both at the infarct border zone (larger infarct size) and in remote areas of the heart.
␤2a Hearts Have Depressed Function After Ischemia/Reperfusion Stress
Our MI experiments suggest that the ␤2a heart is more prone to acute ischemic injury. To more directly test this idea we compared the effects of in vitro ischemia-reperfusion (IR) stress on ventricular performance in isovolumic hearts subjected to 15 minutes of global no flow ischemia, followed by 30 minutes of reperfusion. Before IR, LV developed pressure (LVDP) and ϮdP/dT (mm Hg/s) in ␤2a hearts were significantly greater than in controls ( Figure 3A ; Online Figure III , A and B). During the ischemic period, end diastolic pressure (EDP) became significantly greater in ␤2a hearts versus control, suggesting they develop Ca 2ϩ overload-related increases in diastolic pressure ( Figure 3B through 3C). ␤2a hearts also had greater disruption of contractile function after reperfusion ( Figure 3B ). Recovery of LVDP was significantly reduced in ␤2a versus control hearts ( Figure 3B ) and the EDP was significantly greater in ␤2a hearts than in control hearts ( Figure 3D ). The increased EDP and reduced LVDP are consistent with enhanced Ca 2ϩ stress in the ␤2a that results in SR Ca 2ϩ overload. 26 These results document that ␤2a hearts are prone to ischemia-related injury, without the neuohormonal stressors present in the post-MI heart.
More ␤2a Animals Die After MI and Survivors Have More Pathological Hypertrophy
Animals were studied over a 6 week period after MI. Representative examples of heart and lung morphology in control and ␤2a mice after MI surgery are shown in Online Figure I (D). ␤2a animals were significantly more likely to die after MI than were controls ( Figure 4A ), with only 19% alive after 6 weeks, versus 60% of controls.
Lung weight was significantly increased in ␤2a animals early after MI, documenting more severe acute HF, and returned toward normal in those animals that survived for longer times ( Figure 4B ). Both groups of animals had increased heart weight/body weight (HW/BW) ratio, but in ␤2a mice, HW/BW was increased more than in controls ( Figure 4C ).
To define myocyte hypertrophy, we measured indices of myocyte size in tissue sections of animals euthanized 6 weeks after MI. Myocyte hypertrophy was significantly greater in ␤2a than in control hearts after MI ( Figure 4D through 4G ). These data show that ␤2a animals have exacerbated pathological responses to MI, with enhanced acute heart failure and increased pathological myocyte hypertrophy.
Cardiac Pump Function After MI Was Depressed More in ␤2a Hearts Than in Controls
Echocardiography was used to measure changes in LV function and chamber dimensions after MI (see examples in Online Figure IV, A and B) . In sham animals, LV contractile function was greater in ␤2a versus controls (Figures 1 and 5) . Importantly, cardiac structure and function were stable in sham ␤2a mice throughout the time period of this study ( Figure 5 ). After MI, all animals had reduced pump function and significant enlargement in LV chamber dimensions (dilation) ( Figure 5 ). LV FS and EF were significantly decreased 1 week after MI in control mice (FS, pre-MI versus after MI: 37.4% versus 17.6%; EF, 67.7% versus 38.2%) and ␤2a mice (FS, pre-MI versus after MI: 41.1% versus 19.9%; EF, 72.7% versus 40.8%), and there were now no differences in these functional parameters between ␤2a and control hearts. Over the next few weeks, FS and EF continued to decrease in ␤2a hearts (FS, after MI 2, 4, 6 weeks: 15.5%, 11.5%, 13.2%; EF, 32.7%, 24.7%, 25.4%), whereas in control mice, these functional parameters were stable (FS, after MI 2, 4, 6 weeks: 20.6%, 21.2%, 19.6%; EF: 41.9%, 42.6%, 40.4%) ( Figure 5 ). At the end of 6-week study interval, cardiac function was significantly more depressed in ␤2a versus control hearts. There were significant pathological changes in ventricular geometry and wall thickness after MI (Online Figure IV, A and B). The magnitude of these changes was greater in ␤2a than in control hearts. LV wall thickness was greater in ␤2a versus control hearts before MI. After MI, PWT was decreased in both ␤2a and control hearts (control pre-MI versus post-MI: 1.08 versus 1.00 mm; ␤2a: 1.21 versus 1.06 mm). Over the next 3 weeks, PWT returned to values near pre-MI levels in control hearts, whereas PWT continued to decrease in ␤2a hearts ( Figure 5D ). All hearts showed some evidence of dilation after MI; however, LVID increased significantly more in ␤2a than in control hearts in the first week after MI (control pre-MI versus post-MI: 3.7 versus 4.0 mm; ␤2a: 3.4 versus 4.0 mm). By 4 weeks after MI, LVID was significantly more dilated in ␤2a hearts than in controls (4.2 versus 5.2 mm, Figure 5C ). These results show that MI causes significantly greater deterioration of cardiac function and structure (lower EF, FS, enlarger chamber) in ␤2a mice. (Figure 6A through 6C) . The voltage dependence of I Ca,L activation was shifted to negative potentials in ␤2a myocytes, consistent with the known function of this subunit 29, 30 and with what we have shown previously. 8 After MI, I Ca,L density was decreased in all myocytes but remained significantly larger in ␤2a than in control myocytes (␤2a versus control: Ϫ17.6Ϯ1.4 nϭ15 versus Ϫ10.4Ϯ0.8 pA/pF nϭ12 PϽ0.05) ( Figure 6A through 6C) . I Ca,L density in ␤2a after MI was significantly greater than in control myocytes before MI. I Ca,L is increased by protein kinase A-mediated phosphorylation in normal myocytes. 31 This regulation is altered in myocytes from diseased hearts. 32, 33 We measured the effects of isoproterenol (Iso) on I Ca,L in myocytes from sham and post-MI hearts. In control (sham) myocytes, Iso increased I Ca,L density (pre-Iso versus after Iso: Ϫ13.3Ϯ1.95 to Ϫ17.9Ϯ3.9 pA/pF, nϭ4, PϽ0.05) and caused a significant negative shift in the voltage dependence of I Ca,L activation. Iso had no significant effect on I Ca,L in ␤2a (sham) myocytes (Ϫ22.9Ϯ2.7 versus Ϫ20.2Ϯ0.9 pA/pF, nϭ7) ( Figure 7A , 7C, and 7E; and Online Figure V [A, B, and E] ). After MI, baseline I Ca,L density was reduced in both control and ␤2a myocytes ( Figure 6 ). In control MI myocytes Iso increased I Ca,L but less so than under control conditions (control MI pre-Iso versus after Iso: Ϫ9.4Ϯ1.8 versus Ϫ12.6Ϯ2.7 pA/pF, nϭ6, PϽ0.05) and Iso shifted the voltage dependence of activation to more negative potential ( Figure 7B Collectively, these data show that myocytes from ␤2a MI hearts with cardiac pump function that was worse than in control MI hearts remained hypercontractile.
Contractions and [
Discussion
In the present study, we tested the hypothesis that preventing depression of myocyte contractility after MI improves cardiac pump function and slows heart failure progression. The major findings of this study are that increasing Ca 2ϩ influx through the L-type Ca 2ϩ channel after MI prevents depressed myocyte contractility but increases the risk of ischemic injury, precipitates sudden death, and exacerbates depressed cardiac pump function.
␤2a Hearts Have Depressed Pump Function After Ischemia/Reperfusion
Our studies in isolated hearts show that hypercontractile ␤2a hearts have more depressed contractile function after IR (Figure 3) . EDP was elevated during ischemia and after reperfusion in ␤2a hearts, and systolic function after reperfusion was more depressed than in controls. These results suggest that the higher Ca 2ϩ influx in ␤2a myocytes precipitates SR Ca 2ϩ overload 26 resulting in diastolic and systolic dysfunction and Ca 2ϩ -mediated injury. 34, 35 ␤2a
Hearts Have Larger Infarcts
The AAR after myocardial infarction was not different in control and ␤2a mice; however, infarct size (as a % of AAR) was significantly greater in ␤2a hearts than in controls ( Figure 2 ). Not all portions of the AAR die after MI because the border of the ischemic region receives some blood flow and some myocytes in this region can survive. Our results show that a greater number of myocytes in the border zone died in the ␤2a hearts. The mechanism of enhanced myocyte death is not entirely clear, but we did show an increase in TUNEL ϩ myocytes in the ␤2a infarct border and remote zone, suggesting that apoptotic cell death is increased. We cannot rule out the possibility that necrotic cell death is also increased in ␤2a hearts subjected to MI. 8 The factors that influence myocyte death in the MI border zone are complex and involve ischemia and systemic sympathetic reflex responses. After MI, cardiac pump function decreases and this elicits a reflex sympathetic nervous system 
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response to maintain cardiac output and systemic blood pressure. Because ␤2a hearts have enhanced basal contractility, less sympathetic reflex response might be expected after MI, and this could reduce any damaging effects of sympathetic stimulation on myocyte survival. Because we found larger infarcts in ␤2a hearts we conclude that this primarily results from excess myocyte Ca 2ϩ rather than excessive sympathetic activity.
Cardiac Dysfunction, Wall Thinning, and Chamber Dilation Are Enhanced in ␤2a Hearts After MI MI causes cardiac structural remodeling (wall thinning and dilation). 36 These changes in ventricular size and shape increase systolic wall stress, further increasing the contractile demands on a heart with a reduced number of working myocardial cells. This persistent elevation in wall stress causes progressive decay of myocardial performance and induces heart failure and premature death. 36 Our results show that ␤2a hearts develop more dilation and poorer pump function than controls after MI ( Figure 5 ) and that this was associated with increased rates of myocyte death in the remote zone of the ␤2a heart ( Figure 2F ). The most important finding in our study is that these detrimental changes take place in hearts in which we prevented depressed myocyte contractility ( Figures 6 and 7) , documenting that depressed myocyte contractile function is not a prerequisite for poor cardiac pump function after MI.
Why Is Cardiac Pump Function Depressed in the Dilated Heart?
In patients with heart failure, the dilated heart has a reduced EF, and blood is expelled slowly. 37 The afterload (systolic wall stress) in the failing heart is significantly increased and correlates closely with heart failure severity and prognosis. 38 Many groups, 4 including ours, 8, 39 have shown that Ca 2ϩ handling is deranged in failing myocytes and this depresses myocyte contractility reserve. 5 Pathologically high systolic wall stress and depressed myocyte contractility both reduce the pump function of these hearts. However, it is still not clear whether either or both mechanisms represent the primary cause(s) of heart failure progression. Our study shows that heart failure progresses at a faster rate in mice in which myocyte contractility is maintained after MI ( Figure 5 ).
Heart failure progression is also associated with an increased rate of myocyte death. 8, 25, 40, 41 Our experiments showed that apoptotic myocyte death was increased in remote zones of the ␤2a heart (versus control) after MI (Figure 2 and Online Figure II) . We conclude that MI-induced heart failure influx. 33 SERCA abundance is reduced and phospholamban phosphorylation is reduced to slow the rate of SR Ca 2ϩ uptake and reduce SR Ca 2ϩ loading. 12, 42 The phosphorylation of the SR Ca 2ϩ release channel (ryanodine receptor) is abnormal and this leads to arrhythmias and SR Ca 2ϩ leak. 43 Collectively, theses defects produce a failing heart that must develop high systolic stress with a reduced ability to increase Ca 2ϩ influx and SR Ca 2ϩ uptake and release. These changes in Ca 2ϩ handling have led some to conclude that myocyte force development in the failing heart is less than in the normal heart. This is clearly not the case, because systolic wall stress (force being generated per unit myocardium) is significantly elevated. 38 Although contractility reserve is reduced in these myocytes, the activity of neuroendocrine regulatory mechanisms must provide the stimulus to induce high force generation in vivo. Our present hypothesis is that the persistent need to develop high wall stress (requiring high Ca 2ϩ ) induces the deranged Ca 2ϩ handling that reduces contractility reserve. 5 Therefore, deranged Ca 2ϩ handing may be the effect of rather than the cause of heart failure progression. Our data suggest that downregulation of Ca 2ϩ handling in the diseased heart might provide some protection from high Ca 2ϩ -related injury.
Relevance of the Study
Heart failure is a major health problem in our society. Available therapies provide only modest prolongation of life 44 ; therefore, novel therapies are clearly needed. Importantly, those therapies 44 that show clinical utility are negative inotropic agents (␤-adrenergic antagonists and angiotensin antagonists). Conversely, those therapies that increase contractility have actually increased death rates of heart failure patients. 17, 18 Therefore, increasing Ca 2ϩ stress (contractility) in failing hearts may not be the best strategy for long-term improvement in cardiac pump function. However, we forced Ca 2ϩ handling to be increased by augmenting the most proximal portion of the Ca 2ϩ -handling cascade, Ca 2ϩ influx. Approaches that improve Ca 2ϩ handling by manipulation of more distal elements, such as increasing SERCa2 45 or blocking SR Ca 2ϩ leak 46 might rebalance cardiac contractility without predisposing the cell to Ca 2ϩ overload and cell death.
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Novelty and Significance
What Is Known?
• Persistent hemodynamic stress (from high blood pressure or after a myocardial infarction [MI] ) requires an increase in the contractile strength of cardiac myocytes.
• Increased contractile demand induces a sympathetic response that increases cell Ca 2ϩ and contractility.
• With the development of heart failure, Ca 2ϩ handling becomes abnormal with a reduced ability to maintain high levels of contractile strength (muscle weakening), and there is an increase in myocyte death rate.
• Most pharmacological approaches that increase contractility in human heart failure have not been improved patient outcome.
What New Information Does This Article Contribute?
• Expressing the ␤2a subunit of the L-type Ca 2ϩ channel prevents depression of myocyte contractility after myocardial infarction.
• Maintaining high levels of contractility after MI was associated with an increase in infarction size.
• Maintaining high levels of contractility with ␤2a expression was associated with exacerbation of depressed cardiac pump function and cardiac dilation. This study showed that MI-induced heart failure could be seen in hearts with hypercontractile myocytes.
• Maintaining high Ca 2ϩ and contractility after MI was associated with increased myocyte apoptosis and ventricular dilation.
Myocardial infarction results in a heart with fewer myocytes that must increase their force development to maintain systemic blood pressure. Over time, the heart dilates and fails. Although myocytes in the dilated heart must develop high stress in vivo, they develop contractile defects that limit their peak contractile performance. These changes may also protect myocytes from negative aspects (activation of cell death signaling) of sustained high Ca 2ϩ states. This study tested whether preventing depression of myocyte contractility after MI improves cardiac performance or exacerbates MI related cardiac injury. Our results show that animals with genetically induced increases in myocyte contractility were more prone to stress related injury and death. Maintaining high contractility caused expansion of infarct size and exacerbated cardiac dilation and depressed pump function, even though the ␤2a myocytes remained hypercontractile. These studies suggest that positive inotropic therapy should be performed cautiously because in addition to the increased arrhythmogenic risk of this type of therapy (if it leads to enhanced myocyte Ca 2ϩ ), it has the potential to induce myocyte death, further reducing myocyte number to exacerbate depressed cardiac pump function. Western Blot analysis of PLBt and PLB P Thr17 protein levels in control and β2a hearts after 3 weeks MI. (A). Representative western blot of PLBt and PLB P Thr17 protein from control and β2a hearts . (B). Analysis of abundance of PLBt and PLB P Thr17 protein levels normalized to GAPDH from control (n=3)and β2a hearts (n=3). * p < 0.05.
